Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.05
0.010.96%
Last update: Dec 15, 9:25 AM
Comments
Loading...
Context Therapeutics (CNTX) Stock Price, Quote, News & History
CNTXNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Context Therapeutics (CNTX) stock?
You can purchase shares of Context Therapeutics (NASDAQ:CNTX) through any online brokerage.
Who are Context Therapeutics (CNTX) competitors?
Other companies in Context Therapeutics’s space includes: CalciMedica Inc (NASDAQ:CALC), Rani Therapeutics Holdings Inc (NASDAQ:RANI), Incannex Healthcare Inc (NASDAQ:IXHL), Nutriband Inc (NASDAQ:NTRB) and Anebulo Pharmaceuticals Inc (NASDAQ:ANEB).
What is the forecast, or price target, for Context Therapeutics (CNTX) stock?
Context Therapeutics has a consensus price target of $5.93.
What is the current price for Context Therapeutics (CNTX)?
The stock price for Context Therapeutics (NASDAQ: CNTX) is $1.05 last updated December 15, 2025 at 9:25 AM EST.
Does Context Therapeutics (CNTX) pay a dividend?
There are no upcoming dividends for Context Therapeutics.
When is Context Therapeutics (NASDAQ:CNTX) reporting earnings?
Context Therapeutics does not have any upcoming earnings scheduled.
Is Context Therapeutics (CNTX) going to split?
There is no upcoming split for Context Therapeutics.
What sector and industry does Context Therapeutics (CNTX) operate in?
Context Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
